Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Geretti

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
AIDS Research and Treatment|September 11, 2015
Efficacy of Once Daily Darunavir/Ritonavir in PI-Naïve, NNRTI-Experienced Patients in the ODIN TrialAnna Maria Geretti, Mathe Moeketsi, Ralph Demasi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 30, 2014
Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan AfricaPhilippa C Matthews, Anna Maria Geretti, Philip J R Goulder, et al.
The Journal of Infectious Diseases|March 31, 2010
Antiretroviral drug resistance in HIV-1-infected patients with low-level viremiaNicola E Mackie, Andrew N Phillips, Steve Kaye, et al.
The Journal of Infection|July 1, 2014
Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in GhanaFred Stephen Sarfo, Adetayo Kasim, Richard Phillips, et al.
BMC Infectious Diseases|October 14, 2018
Epidemiology of hepatitis B, C and D in Malawi: systematic reviewAlexander J Stockdale, Collins Mitambo, Dean Everett, et al.
Sexually Transmitted Diseases|January 25, 2006
Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected personsMeghna Ramaswamy, Caroline Sabin, Candice McDonald, et al.
Open Forum Infectious Diseases|November 1, 2018
Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity SettingAdam Abdullahi, Olga Mafotsing Fopoussi, Judith Torimiro, et al.
Open Forum Infectious Diseases|April 11, 2019
Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity SettingAdam Abdullahi, Olga Mafotsing Fopoussi, Judith Torimiro, et al.
BMJ (Clinical Research Ed.)|November 26, 2010
Forgotten, but not goneEmilie Sanchez, Sowsan F Atabani, Jana Kaplanova, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 2, 2013
Comparative evaluation of the Artus HIV-1 QS-RGQ assay and the Abbott RealTime HIV-1 assay for the quantification of HIV-1 RNA in plasmaAna Garcia-Diaz, Wendy Labbett, Gillian S Clewley, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
AIDS Research and Treatment|September 11, 2015
Efficacy of Once Daily Darunavir/Ritonavir in PI-Naïve, NNRTI-Experienced Patients in the ODIN TrialAnna Maria Geretti, Mathe Moeketsi, Ralph Demasi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 30, 2014
Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan AfricaPhilippa C Matthews, Anna Maria Geretti, Philip J R Goulder, et al.
The Journal of Infectious Diseases|March 31, 2010
Antiretroviral drug resistance in HIV-1-infected patients with low-level viremiaNicola E Mackie, Andrew N Phillips, Steve Kaye, et al.
The Journal of Infection|July 1, 2014
Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in GhanaFred Stephen Sarfo, Adetayo Kasim, Richard Phillips, et al.
BMC Infectious Diseases|October 14, 2018
Epidemiology of hepatitis B, C and D in Malawi: systematic reviewAlexander J Stockdale, Collins Mitambo, Dean Everett, et al.
Sexually Transmitted Diseases|January 25, 2006
Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected personsMeghna Ramaswamy, Caroline Sabin, Candice McDonald, et al.
Open Forum Infectious Diseases|November 1, 2018
Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity SettingAdam Abdullahi, Olga Mafotsing Fopoussi, Judith Torimiro, et al.
Open Forum Infectious Diseases|April 11, 2019
Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity SettingAdam Abdullahi, Olga Mafotsing Fopoussi, Judith Torimiro, et al.
BMJ (Clinical Research Ed.)|November 26, 2010
Forgotten, but not goneEmilie Sanchez, Sowsan F Atabani, Jana Kaplanova, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 2, 2013
Comparative evaluation of the Artus HIV-1 QS-RGQ assay and the Abbott RealTime HIV-1 assay for the quantification of HIV-1 RNA in plasmaAna Garcia-Diaz, Wendy Labbett, Gillian S Clewley, et al.
Pageof 18